Cargando…
Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T‐lymphokine‐activated killer cell‐originated protein kinase.
BACKGROUND AND PURPOSE: Overexpression or aberrant activation of the T‐lymphokine‐activated killer cell‐originated protein kinase (TOPK) promotes gene expression and growth of solid tumours, implying that TOPK would be a rational target in developing novel anticancer drugs. Acetylshikonin, a diterpe...
Autores principales: | Zhao, Ran, Choi, Bu Young, Wei, Lixiao, Fredimoses, Mangaladoss, Yin, Fanxiang, Fu, Xiaorong, Chen, Hanyong, Liu, Kangdong, Kundu, Joydeb Kumar, Dong, Zigang, Lee, Mee‐Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174886/ https://www.ncbi.nlm.nih.gov/pubmed/31985814 http://dx.doi.org/10.1111/bph.14981 |
Ejemplares similares
-
3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo
por: Fu, Xiaorong, et al.
Publicado: (2021) -
Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19
por: Lu, Ning, et al.
Publicado: (2022) -
Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway
por: Cui, Jieke, et al.
Publicado: (2022) -
Corrigendum: Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase Protein Kinase
por: Fan, Xiaoming, et al.
Publicado: (2020) -
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
por: Yin, Fanxiang, et al.
Publicado: (2022)